日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

普拉替尼治疗晚期RET融合阳性非小细胞肺癌患者的I/II期ARROW研究的最终疗效和安全性数据

Besse, Benjamin; Subbiah, Vivek; Curigliano, Giuseppe; Bowles, Daniel W; Doebele, Robert C; Mansfield, Aaron S; Baik, Christina S; de Lima Lopes, Gilberto; Paz-Ares, Luis; Taylor, Matthew H; Tan, Daniel S W; Alonso, Guzman; Gadgeel, Shirish M; Kalemkerian, Gregory P; Ou, Sai-Hong Ignatius; van der Wekken, Anthonie J; Becerra, Carlos R; Evangelist, Makenzi; Griesinger, Frank; Liu, Stephen V; Lou, Yanyan; Mazières, Julien; Melear, Jason M; Narang, Mohit; Saxena, Ashish; Thomas, Michael; Wang, Sophia; Thomassen, Amber; Lee, Dae Ho; Kim, Dong-Wan; Gainor, Justin F

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial

Tiragolumab联合Atezolizumab和化疗治疗晚期非鳞状非小细胞肺癌:SKYSCRAPER-06 3期随机临床试验

Socinski, Mark A; Stahel, Rolf; Lee, Dae Ho; Cappuzzo, Federico; Nishio, Makoto; Lovly, Christine M; Ozyilkan, Ozgur; Li, Qingshan; Johnson, Melissa; Garon, Edward B; Kilickap, Saadettin; Ferreira da Silva, Flavio Augusto; Alatorre-Alexander, Jorge; Meng, Raymond; Amin, Reena; Matheny, Christina; Troutman, Sarah; Wen, Xiaohui; Patil, Namrata S; Zou, Wei; Rodriguez-Abreu, Delvys

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

RET 改变实体瘤中选择性 RET 抑制剂耐药的基因组机制图谱:RETregistry 全球联盟分析

Waliany, Sarah; Cooper, Alissa J; Liu, Stephen V; Gautschi, Oliver; Rotow, Julia K; Smith, Katherine Emilie Rhoades; Weber, Urs M; Lee, Dae Ho; Loong, Herbert H F; Patel, Jyoti D; Pennell, Nathan A; Nagasaka, Misako; Patel, Shetal A; Tan, Daniel S W; Solomon, Benjamin J; Kim, Tae Min; Pall, Georg; Riess, Jonathan W; Sun, Lova; Früh, Martin; Uy, Natalie F; Gadgeel, Shirish; Feng, Jamie; Do, Andrew; Falcon, Christina; Leighl, Natasha B; Baik, Christina S; Lai, Gillianne G Y; Ou, S Ignatius; Cheung, Kingsley S Y; Patil, Tejas; Mansfield, Aaron S; Weiler, Daniela; Yeap, Beow Y; Wirth, Lori J; Gainor, Justin F; Drilon, Alexander; Lin, Jessica J

Dynamic Lipidomic Remodeling and Clinical Correlations after Sleeve Gastrectomy in Obese Subjects

肥胖患者袖状胃切除术后动态脂质组重塑及临床相关性

Lee, Gakyung; Lee, Yeong Chan; Park, Minkuk; Kim, Seong Min; Park, Ji-Hyeon; Lee, Dae Ho

Molecular epidemiology and outcomes of EGFR exon 20 insertion in Korean patients with non-small cell lung cancer

韩国非小细胞肺癌患者EGFR 20号外显子插入的分子流行病学及预后

Yoon, Shinkyo; Kim, Seong-Eun; Lim, Sun Min; Jung, Hyun Ae; Kim, Kyu-Pyo; Kim, Dong-Kyu; Jeong, Hyehyun; Lim, Subin; Kim, Jung-Ae; Kim, Joohyun; Patel, Dony; Zhao, Xiahong; Yu, Dae Young; Kim, Ji Hyun; Lee, Dae Ho

Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications

代谢功能障碍相关脂肪肝疾病中的肝脏胰岛素抵抗和脂肪变性:机制和临床意义的新见解

Truong, Xuan Trong; Lee, Dae Ho

MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines.

MED12 突变通过炎症细胞因子激活 MEK/ERK 通路,诱导 NSCLC 对 RTK 抑制剂产生耐药性

Ryu Hyun-Min, Kim Deokhoon, Choi Jun Young, Yoon Shinkyo, Lee Ho-Su, Park Ji Eun, Lee Eunjin, Sung Yunkyung, Lee Chang Hoon, Lee Eun-Young, Kim Wanlim, Seo Seyoung, Kim Sang-We, Park Kang-Seo, Lee Dae Ho

Clinical and histopathological characteristics of melanomas in Asians under age 40

40岁以下亚洲人黑色素瘤的临床和组织病理学特征

Yang, Hee Joo; Kim, Young Jae; Na, Hyoungmin; Jo, Yoon-Seo; Chang, Sung Eun; Eom, Jin Sup; Hong, Yong Sang; Wanlim Kim; Lee, Dae Ho; Lee, Mi Woo; Lee, Woo Jin; Won, Chong Hyun; Lim, Youngkyoung; Lee, Jong Seok

Exon-level TP53 alterations and PD-L1 expression identified by pretreatment NGS stratify survival in EGFR-mutant non-small cell lung cancer treated with first-line osimertinib

通过治疗前NGS检测发现的TP53外显子水平改变和PD-L1表达可对接受一线奥希替尼治疗的EGFR突变型非小细胞肺癌患者的生存期进行分层。

Kim, Seong-Eun; Kim, Yongjae; Yoon, Do Kyung; Park, Hwan; Park, Kang-Seo; Kim, Deokhoon; Hwang, Hee Sang; Ahn, Bokyung; Park, Ji Eun; Kim, Sang-We; Jang, Se Jin; Yoon, Shinkyo; Lee, Ho-Su; Lee, Dae Ho

First-line Selpercatinib or Chemotherapy and Pembrolizumab in Patients From East Asia With RET Fusion-Positive NSCLC: A LIBRETTO-431 Subgroup Analysis

一线治疗RET融合阳性非小细胞肺癌患者(来自东亚):Selpercatinib或化疗联合Pembrolizumab:LIBRETTO-431亚组分析

Goto, Koichi; Loong, Herbert H; Zhou, Caicun; Nishino, Kazumi; Lee, Dae Ho; Lee, Se-Hoon; Chih-Hsin Yang, James; Liu, Dan; Uh, Minji Kim; Han, Hongmei; Puri, Tarun; Lin, Aimee Bence; Cheng, Ying